The Future of Lupus Treatment with Dr. Megan Clowse: What You Need to Know Now
37 Minuten
Beschreibung
vor 7 Monaten
The Future of Lupus Treatment with Dr. Megan Clowse: What
You Need to Know Now
In this special Lupus Awareness Month episode,
I’m sitting down with Dr. Megan Clowse—one of
the leading rheumatologists in the lupus space and a fierce
advocate for women’s health.
We’re talking real talk about what it actually
looks like to live with lupus, manage all the meds, advocate for
yourself in the doctor’s office, and make informed
decisions—especially around pregnancy.
Dr. Clowse breaks down the latest updates from the
PHOENYCS GO trial (a major study on a new lupus
treatment called dapirolizumab pegol), and why
simplifying care is long overdue for lupus warriors.
Whether you're newly diagnosed, considering pregnancy, or just
tired of feeling like no one gets it—this episode is packed with
clarity, validation, and next steps you can take.
What We Talk About:
The biggest struggles lupus warriors face in the healthcare
system
Why medication overload is real—and what’s being done about
it
The latest lupus treatment study (and what it means for us)
How to plan for pregnancy with lupus, not around it
Why your voice matters in your care plan
The importance of community, rest, and support
About Dr. Megan Clowse:
Dr. Clowse is a Duke-based rheumatologist who’s cared for over
1,000 pregnancies in women with lupus. She
founded the Duke Lupus Clinic, created
LupusPregnancy.org, and currently leads research on improving
lupus care—most recently through her work on the PHOENYCS
GO trial with Biogen and UCB.
Find Her Work:
LupusPregnancy.org
ReproRheum.Duke.edu
Duke Lupus Clinic
Tap in and let this episode remind you—you are not alone, and
better care is possible.
DM me your thoughts after listening or tag me @lupusspeaks or
@planwithdrica to keep the conversation going.
Weitere Episoden
57 Minuten
vor 5 Monaten
18 Minuten
vor 5 Monaten
18 Minuten
vor 5 Monaten
22 Minuten
vor 6 Monaten
11 Minuten
vor 6 Monaten
In Podcasts werben
Kommentare (0)